BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1262441)

  • 1. Aldosterone metabolic clearance is normal in low-renin essential hypertension.
    Brown RD
    J Clin Endocrinol Metab; 1976 Apr; 42(4):661-6. PubMed ID: 1262441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.
    Wisgerhof M; Brown RD
    J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines.
    Beretta-Piccoli C; Weidmann P
    Miner Electrolyte Metab; 1984; 10(5):292-300. PubMed ID: 6387428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure].
    Vetter H; Alasso I; Appenheimer M; Weiand H; Stelkens H; Lucas R; Glänzer K; Witassek F; Stumpe KO; Trübestein G; Krück F
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1729-32. PubMed ID: 1013695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decreased metabolic clearance rate of aldosterone in benign essential hypertension.
    Nowaczynski W; Kuchel O; Genest J
    J Clin Invest; 1971 Oct; 50(10):2184-90. PubMed ID: 5116208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of clonidine on renin and aldosterone of hypertensive patients.
    Salvetti A; Pedrinelli R; Cavasinni L; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):50-6. PubMed ID: 6989768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
    Williams GH; Dluhy RG; Moore TJ
    Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension.
    Marks AD; Marks DB; Kanefsky TM; Adlin VE; Channick BJ
    J Clin Endocrinol Metab; 1979 Feb; 48(2):266-70. PubMed ID: 429480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassim-aldosterone-renin interrelationships.
    Himathongkam T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1975 Jul; 41(1):153-9. PubMed ID: 1167307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension.
    Tuck ML; Williams GH; Dluhy RG; Greenfield M; Moore TJ
    Circ Res; 1976 Nov; 39(5):711-7. PubMed ID: 975459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of beta-blockade on aldosterone metabolism under normal and low sodium diet in man.
    Plouin PF; Corvol P; Menard J
    Biomedicine; 1977 Jul; 27(6):233-5. PubMed ID: 907802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and hyperkalaemia responding to bendrofluazide.
    Lee MR; Ball SG; Thomas TH; Morgan DB
    Q J Med; 1979 Apr; 48(190):245-58. PubMed ID: 504550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential arterial hypertension: plasma and urinary aldosterone alterations.
    Garcia Zozaya JL; Padilla Viloria M; Castro A
    South Med J; 1987 Oct; 80(10):1224-7. PubMed ID: 3310248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension.
    London GM; Safar ME; Weiss YA; Corvol PL; Menard JE; Simon AC; Milliez PL
    Arch Intern Med; 1977 Aug; 137(8):1042-7. PubMed ID: 327963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
    Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H
    Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.